§ Funding Round
Series B funding round for Kailera Therapeutics raising $600M in October 2025
Series B funding round for Kailera Therapeutics raising $600M in October 2025
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Angel | gotham makker | |
| Angel | michael gladstone | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
andrew kaplanLEAD | Angel | andrew kaplan |
| Organization | — | |
Janus Henderson Investors | — | — |
Perseverance Capital Management | — | — |
| Organization | — | |
Royalty Pharma | — | — |
| Angel | roderick wong | |
| Organization | — | |
Surveyor Capital | — | — |
T. Rowe Price Associates | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$1B
Top Valuation
-
Kailera Therapeutics raised $600M in a Series B round.
The round was announced on 10/01/25.
The round was led by andrew kaplan.
